Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AURA SYSTEMS INCFinancial_Report.xls
EX-32.1 - AURA SYSTEMS INCexhibit321.htm
EX-10.64 - AURA SYSTEMS INCexhibit1064.htm
EX-10.63 - AURA SYSTEMS INCexhibit1063.htm
EX-31.2 - AURA SYSTEMS INCexhibit312.htm
EX-31.1 - AURA SYSTEMS INCexhibit311.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


Form 10-Q


[] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended.................................................November 30, 2011
OR

[   ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from..........................to.............................

AURA SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)

Delaware
95-4106894
(State or other jurisdiction
(I.R.S. Employer Identification No.)
of incorporation or organization)
 

1310 E. Grand Ave.
El Segundo, California 90245
(Address of principal executive offices)

Registrant's telephone number, including area code: (310) 643-5300

Former name, former address and former fiscal year, if changed since last report:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:         YES [ X ]  NO [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).         YES [ X ]  NO [   ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated file, a non-accelerated filer, or a smaller reporting company (as defined in Rule 12b-2 of the Act).


Large Accelerated Filer 
 
Accelerated Filer 
Non-accelerated filer 
 
Smaller Reporting Company [x]


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes  No [x]

 
1

 


APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes  No


Indicate the number of shares outstanding of each of the issuer's classes of Common Stock, as of the latest practicable date.

Class
Outstanding December 31, 2011
   
Common Stock, par value $0.0001 per share
71,845,208 shares


 
2

 


AURA SYSTEMS, INC.
 
INDEX
 
 Index
   
Page No.
PART I.
FINANCIAL INFORMATION
   
       
 
ITEM 1.
Financial Statements (Unaudited)
 
       
   
Condensed Balance Sheets as of November 30, 2011 and February 28, 2011
4
       
   
Condensed Statements of Operations for the Three and Nine Months Ended November 30, 2011 and 2010
5
       
   
Condensed Statements of Cash Flows for the Nine Months Ended November 30, 2011 and 2010
6
       
   
Notes to Condensed Financial Statements
7
       
 
ITEM 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
14
       
 
ITEM 4T.
Controls and Procedures
19
       
PART II.
OTHER INFORMATION
   
       
 
ITEM 2.
Unregistered Sales of Equity Securities and Use of Proceeds
20
       
 
ITEM 6.
Exhibits
20
       
 
SIGNATURES AND CERTIFICATIONS
21


 
3

 


 
PART I.  FINANCIAL INFORMATION
 
ITEM 1. FINANCIAL STATEMENTS AURA SYSTEMS, INC.
CONDENSED BALANCE SHEETS
AS OF NOVEMBER 30, 2011 AND FEBRUARY 28, 2011
(Unaudited)
 

 
   
November 30
   
February 28
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ 146,257     $ 104,815  
Accounts receivable, net of allowance for doubtful accounts of $59,070 at November 30, 2011 and February 28, 2011, respectively
    546,984       296,297  
Inventory - current
    1,000,000       1,000,000  
Other current assets
    650,743       450,843  
Total current assets
    2,343,984       1,851,955  
                 
Property, plant, and equipment, net
    243,402       380,842  
Inventory, non-current, net of allowance for obsolete inventory of $1,952,282 and $2,106,391 at November 30, 2011 and February 28, 2011, respectively
    2,032,979       2,274,013  
Total assets
  $ 4,620,365     $ 4,506,810  
           
LIABILITIES AND STOCKHOLDERS' DEFICIT
         
Current liabilities:
               
Accounts payable
  $ 624,706     $ 1,945,372  
Accrued expenses
    905,065       2,632,856  
Customer advances
    77,872       336,308  
Notes payable
    -       82,500  
Convertible notes payable
    333,213       290,000  
Notes payable and accrued interest- related party
    11,367,506       10,148,352  
Total current liabilities
    13,308,362       15,435,388  
                 
Convertible notes payable
    238,010       500,000  
                 
Total liabilities
    13,546,372       15,935,388  
                 
Commitments and contingencies
    -       -  
                 
Stockholders' deficit :
               
Common stock, $0.0001 par value; 150,000,000 and 75,000,000 shares authorized at November 30, 2011 and February 28, 2011; 71,445,208 and 60,720,956 shares issued and outstanding at November 30, 2011 and February 28, 2011
    7,144       6,072  
Additional paid-in capital
    393,420,722       379,819,510  
Accumulated deficit
    (402,353,873 )     (391,254,160 )
Total stockholders' deficit
    (8,926,007 )     (11,428,578 )
Total liabilities and stockholders' deficit
  $ 4,620,365     $ 4,506,810  
 

 
See accompanying notes to these Unaudited condensed financial statements.

 
4

 


AURA SYSTEMS, INC.
CONDENSED STATEMENTS OF OPERATIONS
THREE AND NINE MONTHS ENDED NOVEMBER 30, 2011 AND 2010
(Unaudited)

   
Three Months
   
Nine Months
 
   
2011
   
2010
   
2011
   
2010
 
Net Revenues
  $ 527,185     $ 1,250,255     $ 2,093,955     $ 2,835,722  
                                 
Cost of goods sold
    341,802       698,517       997,948       1,482,364  
                                 
Gross Profit
    185,383       551,738       1,096,007       1,353,358  
                                 
Expenses
                               
Engineering, research and development expenses
    337,631       472,045       993,411       1,284,700  
Selling, general and administrative expenses
    2,895,689       2,121,240       10,755,327       7,197,289  
Total costs and expenses
    3,233,320       2,593,285       11,748,738       8,481,989  
                                 
Loss from operations
    (3,047,937 )     (2,041,547 )     (10,652,731 )     (7,128,631 )
                                 
Other income and (expense)
                               
Interest expense, net
    (672,372 )     (211,663 )     (1,176,358 )     (670,284 )
Gain(Loss) on settlement of debt
    447,585       -       714,340       (57,032 )
Other income (expense), net
    85       (826 )     15,036       (5,129 )
Total other income (expense)
    (224,702 )     (212,489 )     (446,982 )     (732,445 )
Net Loss
  $ (3,272,639 )   $ (2,254,036 )   $ (11,099,713 )   $ (7,861,076 )
                                 
Total basic and diluted loss per share
  $ (0.05 )   $ (0.04 )   $ (0.17 )   $ (0.14 )
Weighted average shares used to compute basic and diluted income (loss) per share*
    70,131,472       56,123,980       66,621,897       54,672,840  

*Basic and diluted weighted average number of shares outstanding are equivalent because the effect of potential dilutive securities is anti-dilutive.
 
See accompanying notes to these un-audited condensed financial statements.
 

 
5

 

 

 
AURA SYSTEMS, INC.
CONDENSED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED NOVEMBER 30, 2011 AND 2010
(Unaudited)

   
2011
   
2010
 
Cash flow from operating activities:
           
Net Loss
  $ (11,099,713 )   $ (7,861,076 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
Depreciation expense
    137,440       140,083  
Amortization of debt discount
    366,830       72,000  
(Gain) loss on settlement of debt
    (714,340 )     57,032  
Provision for inventory obsolescence
    (154,109 )     -  
Amortization
    266,135       -  
Stock options and warrants expense
    3,750,513       128,999  
Stock issued for services
    510,000       803,000  
Beneficial conversion feature on convertible debt
    70,641       -  
(Increase) decrease in:
               
Accounts receivable
    (250,687 )     (392,415 )
Inventory
    395,143       143,164  
Other current assets and deposit
    (33,326 )     36,268  
Cash overdraft
    -       67,393  
Accounts payable, customer deposit and accrued expenses
    763,895       2,210,963  
Net cash used in operations
    (5,991,578 )     (4,594,589 )
                 
Investing activities:
               
Acquisition of plant and equipment
    -       (9,599 )
                 
Financing activities:
               
Issuance of common stock
    1,453,520       1,453,894  
Proceeds from stock to be issued
    -       50,000  
Proceeds from notes payable, net
    3,604,500       145,000  
Proceeds from notes payable, related party, net
    975,000       2,910,000  
                 
Net cash provided by financing activities
    6,033,020       4,558,894  
                 
Net increase (decrease) in cash & cash equivalents
    41,442       (45,294 )
                 
Cash and cash equivalents at beginning of period
    104,815       45,294  
                 
Cash and cash equivalents at end of period
  $ 146,257     $ -  
                 
Supplemental disclosures of cash flow information
               
Cash paid during the period for:
               
Interest
  $ 60,136     $ 17,562  
 
Supplemental disclosure of non-cash investing and financing activities:
 
 
During the nine months ended November 30, 2011, $1,515,960 of notes payable and accrued interest were converted into 2,227,612 shares of common stock, $599,492 of accounts payable was settled with 908,593 shares of common stock, 3,042,199 shares of common stock were issued in settlement of accrued and unpaid compensation of $2,259,865 and 1,225,000 shares of common stock were issued for services rendered valued at $885,000.
 
 
See accompanying notes to these Unaudited condensed financial statements.
 

 
6

 

 
AURA SYSTEMS, INC.
 
 
NOTES TO CONDENSED FINANCIAL STATEMENTS
 
 
(Unaudited)
 
 
NOTE 1 - ACCOUNTING POLICIES
 
 
Accounting principles
 
 
In the opinion of management, the accompanying balance sheets and related interim statements of income and comprehensive income, and cash flows include all adjustments, consisting only of normal recurring items, necessary for their fair presentation in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s 2011 Form 10-K filed on June 14, 2011 with the U.S. Securities and Exchange Commission.
 
 
Estimates
 
 
The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
 
 
Recently Issued Accounting Pronouncements
 
 
In December 2011, the FASB issued guidance on offsetting (netting) assets and liabilities. Entities are required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. The new guidance is effective for annual periods beginning after January 1, 2013.
 
 
In September 2011, the FASB issued guidance on testing goodwill for impairment. The new guidance provides an entity the option to first perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines that this is the case, it is required to perform the currently prescribed two-step goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment loss to be recognized for that reporting unit (if any). If an entity determines that the fair value of a reporting unit is less than its carrying amount, the two-step goodwill impairment test is not required. The new guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011, with early adoption permitted.
 
 
In June 2011, the FASB issued guidance on presentation of comprehensive income. The new guidance eliminates the current option to report other comprehensive income and its components in the statement of changes in equity. Instead, an entity will be required to present either a continuous statement of net income and other comprehensive income or in two separate but consecutive statements. The new guidance is effective for annual periods beginning after December 15, 2011. In December 2011, the FASB issued a deferral of certain portion of this guidance.
 
 
In May 2011, the FASB issued guidance to amend the accounting and disclosure requirements on fair value measurements. The new guidance limits the highest-and-best-use measure to nonfinancial assets, permits certain financial assets and liabilities with offsetting positions in market or counterparty credit risks to be measured at a net basis, and provides guidance on the applicability of premiums and discounts. Additionally, the new guidance expands the disclosures on Level 3 inputs by requiring quantitative disclosure of the unobservable inputs and assumptions, as well as description of the valuation processes and the sensitivity of the fair value to changes in unobservable inputs. The new guidance is effective for annual periods beginning after December 15, 2011.
 
 

 
 
7

 
 
Reclassifications
 
 
Certain reclassifications have been made to the comparative financial statements to conform to the current period presentation.
 
 
NOTE 2 – GOING CONCERN
 
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.  During the nine-months ended November 30, 2011 and November 30, 2010, the Company incurred losses of $11,099,713 and $7,861,076, respectively and had negative cash flows from operating activities of $5,991,578 and $4,594,589, respectively.
 
 
In view of the matters described in the preceding paragraph, recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon continued operations of the Company, which in turn is dependent upon the Company’s ability to increase profitability from operations, obtain financing, and succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts or classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
 
 
Management has taken the following steps to revise its operating and financial requirements, which it believes are sufficient to provide the Company with the ability to continue as a going concern:
 
 
During the next twelve months we intend to continue to expand our AuraGen/Viper business both domestically and internationally. There are four major components necessary to execute a significantly expanding business; (i) augmentation of management and staff, (ii) customers (iii) facilities and equipment, and (iv) working capital.
 
 
Over the next 12 months, we plan to add quality assurance and quality control staff, a number of mechanical, electrical and test engineers and some support staff.  We also plan to augment our management team by hiring a chief operating officer and a chief financial officer as well as a few program managers. We also plan to expand our board from five members to seven with the additional members to be outside independent members. We expect to start a search for a CEO as our current CEO indicated his plans to retire.
 
 
We are selling systems for all of the applications currently identified in our business model for fiscal 2012. In addition, we are also in the process of enhancing our product line to address an even larger market segment.  We currently provide 5 kW, 8.5 kW and 16 kW solutions and we plan to introduce during the next twelve months a 3 kW DC only solution, a 4kW AC solution, 10/20 kW solution (20 kW is a dual stacked system), 15/30 kW solution (30 kw dual stacked system) and a 60/120 kW 120kW is a dual stacked system) solutions.  While there can be no assurances given that we will complete all the developments described above and be able to commercialize them in the planned time, our business model for fiscal 2013 does not contemplate sales for any product not currently available.
 
 
NOTE 3 – INVENTORIES
 
 
Inventories, stated at the lower of cost (first in first out), or market consisted of the following:
 
   
November 30, 2011
   
February 28, 2011
 
             
Raw materials
  $ 2,373,318     $ 2,394,502  
Finished goods
    2,611,942       2,985,902  
      4,985,260       5,380,404  
Reserve for potential product obsolescence
    (1,822,517 )     (1,991,241 )
      3,162,743       3,389,163  
Non-current portion
    (2,032,979 )     (2,274,013 )
Discount on long term inventory
    (129,764 )     (115,150 )
Current portion
  $ 1,000,000     $ 1,000,000  
 
We assessed the net realize-ability and the related potential obsolescence of inventory. In accordance with this assessment, management has recorded a reserve of $1,822,517 and $1,991,241 as of November 30 and February 28, 2011, respectively. Management has also recorded a discount on long term inventory of $129,764 and $115,150 as of November 30, 2011 and February 28, 2011, respectively.
 
 
8

 
 
NOTE 4 – OTHER CURRENT ASSETS
 
 
Other assets of $650,743 and $450,843 are primarily comprised short term deposits of $448,537 and $376,666 as of November 30, 2011 and February 28, 2011.
 
 
NOTE 5 – PROPERTY, PLANT, AND EQUIPMENT
 
 
Property, plant, and equipment consisted of the following:
 
   
November 30, 2011
   
February 28, 2011
 
             
Machinery and equipment
  $ 964,111     $ 964,111  
Furniture and fixtures
    163,302       163,302  
Leasehold improvements
    485,080       485,080  
      1,612,493       1,612,493  
Less accumulated depreciation
    (1,369,091 )     (1,231,651 )
Property, plant and equipment, net
  $ 243,402     $ 380,842  
 
Depreciation expense was $137,440 and $140,083 for the nine months ended November 30, 2011 and November 30, 2010, respectively.
 
 
NOTE 6 – NOTES PAYABLE
 
 
Notes payable consisted of the following:
 
   
November 30, 2011
   
February 28, 2011
 
             
Demand note payable, at 10%
  $ -     $ 82,500  
Convertible note payable, at 7%, convertible into common stock at $3 per share plus accrued interest, due in May 2013. This note was converted into 666,667 shares at face value plus $17,522 of accrued interest on November 30, 2011.
    -       500,000  
Convertible note payable, at 10%, convertible into common stock at $0.75 per share plus accrued interest, due in September2011. This note was converted into 325,612 shares at face value plus $40,953 of accrued interest as of November 30, 2011.
    -       200,000  
Convertible note payable, at 10%, convertible into common stock at $0.75 per share plus accrued interest, due in September 2011.
    -       90,000  
Senior secured convertible note dated September 23, 2011, due March 23, 2013, with 12 monthly payments commencing April 23, 2012 of $306,250 per month. The notes have a stated interest rate of 0%, with prepaid interest of $175,000. Balance net of Beneficial Conversion Feature at September 30, 2011
    571,223       -  
      571,223       872,500  
                 
Less: Current portion
  $ 333,213     $ 372,500  
                 
Long-term portion
  $ 238,010     $ 500,000  
 
 
9

 
 
CONVERTIBLE DEBT
 
On September 23, 2011, Aura Systems, Inc. entered into a purchase agreement to sell convertible notes with a total principal value of $3,675,000 and warrants to purchase shares of common stock to investment fund managed by MDB Capital Group.  The notes have a 1.5 year maturity date and are convertible into shares of common stock at the initial conversion price of $0.75 per share.  The warrants entitle the investors to acquire 4,900,000 & 490,000 shares of common stock and have an initial exercise price of $1 &$0.75 per share, respectively and have a 5 year term. The proceeds of the Convertible note were allocated  between the warrants and convertible note per ASC 470-20. The company recorded $175,000 as a discount(prepaid interest), $1,006,482 as capitalized financing cost  and a discount of $1,790,482 on shares to be issued upon conversion of the note into equity. This discount(prepaid interest), capitalized finance cost and discount will be amortized over the life of the note

 
NOTE 7 – NOTES PAYABLE – RELATED PARTY
 
 
Related party notes payable consisted of the following:
 
   
November 30, 2011
   
February 28, 2011
 
             
Demand  note payable, at 10%, due on demand to a member of our board of directors.
  $ 8,500,000     $ 8,500,000  
Demand  note payable, at 10%, due on demand to a member of our board of directors.
    975,000       -  
Convertible note payable, at 10%, convertible into common stock at $0.75 per share plus accrued interest, due on demand to our CEO. This note was converted into 540,661 shares at face value plus $45,496 of accrued interest as of November 30, 2011.
    -       360,000  
Convertible note payable, at 10%, convertible into common stock at $0.75 per share plus accrued interest, due on demand to our former president. This note was converted into 105,413 shares at face value plus $11,331of accrued interest as of November 30, 2011.
    -       50,000  
Accrued interest
    1,892,506       1,238,352  
    $ 11,367,506     $ 10,148,352  
                 
 
NOTE 8 - ACCRUED EXPENSES
 
 
Accrued expenses consisted of the following:
 
   
November 30, 2011
   
February 28, 2011
 
             
Accrued payroll and related expenses
  $ 861,740     $ 2,520,107  
Accrued interest
    -       112,749  
Other
    43,325       -  
Total
  $ 905,065     $ 2,632,856  
 
Accrued payroll and related expenses consisted primarily of salaries accrued but not paid to certain employees. As of November 30, 2011 and February 28, 2011, these amounts total $524,989 and $1,889,420, respectively. Also included in this amount is accrued vacation expense of $243,948 and $584,065 at November 30, 2011 and February 28, 2011, respectively.
 
 

 
10

 
 
 
NOTE 9–SHAREHOLDERS’ EQUITY
 
 
Common Stock
 
 
During the nine months ended November 30, 2011, we issued 2,460,849 shares of Common Stock for cash consideration of $1,453,520. We also issued 2,227,612 shares of Common Stock for the conversion of $1,515,960 of notes payable and accrued interest, 1,225,000 shares of Common Stock for services to be rendered in the amount of $885,000, 908,593 shares of Common Stock in satisfaction of $599,492 of accounts payable, 859,999 shares as finders fees, and 3,042,199 shares of Common Stock in satisfaction of $2,259,865 of accrued and unpaid compensation.
 
 
During the nine months ended November 30, 2010, we issued 2,700,766 shares of Common Stock for cash consideration of $1,453,894. We also issued 338,408 shares of Common Stock for the conversion of $181,852 of notes payable and accrued interest, 1,093,384 shares of Common Stock for investor relations services, marketing services, and finders fees related to financing, valued at $803,000, and 367,619 shares of  Common Stock for the settlement of $270,029 of accounts payable. We also received $50,000 for 100,000 shares which were issued subsequent to the quarter end and are recorded as shares to be issued.
 
 
Employee Stock Options
 
 
During the nine months ended November 30, 2011, the Company granted 1,319,000 options to certain employees.  These options vest over three years, have an exercise price of $1.00, and have a five year life.  The grant date fair value of these options amounted to $503,933 which was calculated using the Black-Scholes option pricing model with the following assumptions:  risk free rate of return of 1.12%, volatility of 78.99%, a dividend yield of 0%, and an expected life of 5 years.
 
 
In September, 2006, our Board of Directors adopted the 2006 Employee Stock Option Plan. Activity in this plan is as follows:
 
   
2006 Plan
     
   
Weighted-Average Exercise Price
 
Aggregate Intrinsic Value
 
Number of Options
Outstanding, February 28, 2011
 
$0.75
 
$0.00
 
5,304,500
Granted
 
$0.75-$1.00
 
$0.00
 
1,319,000
Cancelled
 
$0.75
 
$0.00
 
(207,278)
Outstanding, November 30, 2011
 
$0.75-$1.00
 
$0.00
 
6,416,222
 
The exercise prices for the options outstanding at November 30, 2011, and information relating to these options is as follows:
 
Options Outstanding
 
Exercisable Options
 
Range of Exercise
Price
 
Number
 
Weighted Average Remaining Life
 
Weighted Average Exercise Price
 
Weighted Average Remaining Life
 
Number
 
Weighted Average Exercise Price
 
  $0.75-$1.00
   
6,416,222
   
3.1 years
 
$
0.80
   
2.8 years
   
5,000,305
 
$
0.76
 
 

 
 

 
11

 
 
 

 
 
Warrants
 
 
Activity in issued and outstanding warrants is as follows:
 
 
Number of Shares
 
Exercise Prices
Outstanding, February 28, 2011
8,688,576
 
$0.75-$4.00
Granted
23,102,787
 
$1.00-$1.50
Expired
(275,808)
 
$1.00-$4.00
Outstanding, November 30, 2011
31,515,555
 
$0.75-$4.00
 
During the nine months ended November 30, 2011, the Company granted 9,400,000 warrants to certain employees & directors.  These warrants vest immediately, have an exercise price of $1.00, and have a five year life.  The grant date fair value of these warrants amounted to $3,562,578 which was calculated using the Black-Scholes option pricing model with the following assumptions:  
 
 
Stock Warrants Granted
 
 
 
 
Risk free rate of return
 
 
 
 
Volatility
 
 
Dividend Yield
 
Expected Life
 
 9,000,000  0.98%  78.99%  0%  5 years
 400,00  0.625%  78.83%  0%  5 years
 
 
The exercise prices for the warrants outstanding at November 30, 2011, and information relating to these warrants is as follows:
 
 
 
 
Range of Exercise Prices
 
 
 
 
Stock Warrants Outstanding
 
 
 
 
Stock Warrants Exercisable
 
 
Weighted-Average Remaining Contractual Life
 
Weighted-Average Exercise Price of Warrants Outstanding
 
Weighted-Average Exercise Price of Warrants Exercisable
 
 
 
 
Intrinsic Value
$1.00
 
6,225,000
 
5,825,000
 
58 months
 
$1.00
 
$1.00
 
$0.00
$1.00
 
16,722,787
 
8,872,787
 
56 months
 
$1.00
 
$1.00
 
$0.00
$1.50
 
155,000
 
155,000
 
52 months
 
$1.50
 
$1.50
 
$0.00
$0.75-1.50
 
2,693,286
 
2,693,286
 
38 months
 
$0.90
 
$0.90
 
$0.00
$0.75-1.25
 
1,314,710
 
1,314,710
 
32 months
 
$1.25
 
$1.25
 
$0.00
$1.50
 
1,900,000
 
1,900,000
 
31 months
 
$1.50
 
$1.50
 
$0.00
$1.00-$4.00
 
1,934,991
 
1,934,991
 
      5 months
 
$3.90
 
$3.90
 
$0.00
$4.00
 
569,781
 
569,781
 
2 months
 
$4.00
 
$4.00
 
$0.00
   
31,515,555
 
23,265,555
               
 
NOTE 10 –INCOME TAXES
 
 
Our effective tax rates were approximately 0.0% for the nine months ended November 30, 2011 and 2010. Our effective tax rate was lower than the U.S. federal statutory rate primarily due to the fact that we record a full valuation allowance against our deferred tax assets, which is primarily comprised of net operating losses.
 
 

 
 
12

 
 

 
 
NOTE 11 - SEGMENT INFORMATION
 
 
We are a United States based company providing advanced technology products to various industries. The principal markets for our products are North America, Europe, and Asia.  All of our operating long-lived assets are located in the United States. We operate in one segment.
 
 
Total net revenues from customer geographical segments is as follows:
 
   
November 30, 2011
   
November 30, 2010
 
             
United States
  $ 1,511,131     $ 2,083,848  
Canada
    467,184       430,786  
Europe
    59,247       6,580  
Asia
    34,725       307,008  
Other
    21,668       7,500  
Total
  $ 2,093,955     $ 2,835,722  
 
NOTE 12 – COMMITMENTS AND CONTINGENCIES
 
 
Concentration Risk
 
 
In the nine months ended November 30, 2011, we sold AuraGen related products to four significant customers whose sales comprised 35%, 33%, 25% and 15% of net sales, respectively. Net accounts receivable from these customers at November 30, 2011 were $47,936, $152,175, $155,035 and $21,843 respectively. These customers are not related to or affiliated with us. In the nine months ended November 30, 2010, we sold AuraGen related products to four significant customers whose sales comprised 26%, 24%, 19% and 11% of net sales, respectively.  These customers are not related to or affiliated with us.
 

 
13

 

 

 
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward Looking Statements
 
This Report contains forward-looking statements within the meaning of the federal securities laws.  Statements other than statements of historical fact included in this Report, including the statements under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” regarding future events or prospects are forward-looking statements. The words “approximates,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans” “would  “should,” “may,” or other similar expressions in this Report, as well as other statements regarding matters that are not historical fact, constitute forward-looking statements. We caution investors that any forward-looking statements presented in this Report are based on the beliefs of, assumptions made by, and information currently available to, us. Such statements are based on assumptions and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance and some will inevitably prove to be incorrect. As a result, our actual future results may differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements to anticipate future results or trends.
 
 
Some of the risks and uncertainties that may cause our actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements include the following:
 
·  
Our ability to generate positive cash flow from operations;
·  
Our ability to obtain additional financing to fund our operations;
·  
Our business development and  operating development; and
·  
Our expectations of growth in demand for our products.

 
For further information regarding these and other risks and uncertainties, we refer you to Part I, Item 1A of our Form 10-K for the fiscal year ended February 28, 2011.
 

 
We do not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent required by law. You should interpret all subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf as being expressly qualified by the cautionary statements in this Report. As a result, you should not place undue reliance on these forward-looking statements.
 
 
Overview
 
 
We design, assemble and sell the AuraGen®, our patented mobile power generator that uses the engine of a vehicle to generate power. The AuraGen® delivers on-location, plug-in electricity for any end use, including industrial, commercial, recreational and military applications. We began commercializing the AuraGen® in late 1999. To date, AuraGen® units have been sold in numerous industries, including recreational, utilities, telecommunications, emergency/rescue, public works, catering, oil and gas, transportation, government and the military.
 
 
We have not yet achieved a level of AuraGen® sales sufficient to generate positive cash flow. Accordingly, we have depended on repeated infusions of cash in order to maintain liquidity as we have sought to develop sales.
 
 
Our financial statements included in this report have been prepared on the assumption that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. However, as a result of our losses from operations, there is substantial doubt about our ability to continue as a going concern. Our independent auditors, in their report on the Company’s financial statements for the year ended February 28, 2011 expressed substantial doubt about the Company’s ability to continue as a going concern.   The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amount and classification of liabilities that August result from our possible inability to continue as a going concern.
 
 
 
14

 
 
Our ability to continue as a going concern is dependent upon the successful achievement of profitable operations, and the ability to generate sufficient cash from operations and obtain financing resources to meet our obligations.  There is no assurance that such efforts will be successful.
 
 
Our current level of sales reflects our efforts to introduce a new product into the marketplace. Many purchases of the product are being made for evaluation purposes. We seek to achieve profitable operations by obtaining market acceptance of the AuraGen® as a competitive - if not superior - product providing mobile power, thereby causing sales to increase dramatically to levels which support a profitable operation. There can be no assurance that this success will be achieved.
 
Critical Accounting Policies and Estimates
 
Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statements requires management to make estimates and disclosures on the date of the financial statements. On an on-going basis, we evaluate our estimates, including, but not limited to, those related to revenue recognition. We use authoritative pronouncements, historical experience and other assumptions as the basis for making judgments. Actual results could differ from those estimates. We believe that the following critical accounting policies affect our more significant judgments and estimates in the preparation of our consolidated financial statements.
 
Revenue Recognition
 
We are required to make judgments based on historical experience and future expectations, as to the reliability of shipments made to our customers. These judgments are required to assess the propriety of the recognition of revenue based on Staff Accounting Bulletin ("SAB") No. 101, "Revenue Recognition," and related guidance. Because sales are currently in limited volume and many sales are for evaluative purposes, we have not booked a general reserve for returns. We will consider an appropriate level of reserve for product returns when our sales increase to commercial levels.
 
Inventory Valuation and Classification
 
Inventories consist primarily of components and completed units for our AuraGen® product. Inventories are valued at the lower of cost (first-in, first-out) or market. Provision is made for estimated amounts of current inventories that will ultimately become obsolete due to changes in the product itself or vehicle engine types that go out of production. Due to continuing lower than projected sales, we are holding inventories in excess of what we expect to sell in the next fiscal year. The net inventories which are not expected to be realized within a 12-month period based on current sales forecasts have been reclassified as long term. Management believes that existing inventories can, and will, be sold in the future without significant costs to upgrade it to current models and that the valuation of the inventories, classified both as current and long-term assets, accurately reflects the realizable values of these assets. The AuraGen® product being sold currently is not technologically different from those in inventory. Existing finished goods inventories can be upgraded to the current model with only a small amount of materials and manpower. We make these assessments based on the following factors: i) existing orders, ii) age of the inventory, iii) historical experience and iv) our expectations as to future sales. If expected sales volumes do not materialize, there would be a material impact on our financial statements.
 
Valuation of Long-Lived Assets
 
Long-lived assets, consisting primarily of property and equipment, and patents and trademarks, comprise a portion of our total assets.  Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that their carrying values August not be recoverable. Recoverability of assets is measured by a comparison of the carrying value of an asset to the future net cash flows expected to be generated by those assets. Net cash flows are estimated based on expectations as to the realize-ability of the asset. Factors that could trigger a review include significant changes in the manner of an asset’s use or our overall strategy.
 
 

 
15

 
 
 
Specific asset categories are treated as follows:
 
 
Accounts Receivable: We record an allowance for doubtful accounts based on our expectation of collect-ability of current and past due accounts receivable.
 
 
Property, Plant and Equipment: We depreciate our property and equipment over various useful lives ranging from five to ten years. Adjustments are made as warranted when market conditions and values indicate that the current value of an asset is less than its net book value.
 
 
When we determine that an asset is impaired, we measure any such impairment by discounting an asset’s realizable value to the present using a discount rate appropriate to the perceived risk in realizing such value. When we determine that an impaired asset has no foreseeable realizable value, we write such asset down to zero.
 
 
Results of Operations
 
 
Three months ended November 30, 2011 compared to three months ended November 30, 2010
 
 
Net revenues for the three months ended November 30, 2011 (the “Third Quarter FY2012”) decreased $723,070 to $527,185 from $1,250,255 in the three months ended November 30, 2010 (the “Third Quarter FY2011”), a decrease of 58%. Subsequent to the end of the Third Quarter FY2012, an ongoing customer placed an order for approximately $610,000 to be delivered in the fourth quarter. This customer in the past has typically ordered for delivery in the third quarter, thereby accounting for most of the Third Quarter FY2012 sales decline. Our customers typically order on an as needed basis and therefore our sales can fluctuate substantially between periods based on our customers’ needs at a given time.
 
 
Cost of goods decreased $356,715 (51%) to $341,802 in the Third Quarter FY2012 from $698,517 in the Third Quarter FY2011. The decrease in cost of goods is primarily a result of the decrease in sales, combined with the differences in gross margins between the 8kW and 5kW systems.
 
 
Engineering, research and development expenses decreased $134,414 (28%) to $337,631 in the Third Quarter FY2012 from $472,045 in the Third Quarter FY 2011. We have continued to reduce our expenditures in this area due to our financial situation.
 
 
Selling, general and administrative expense increased $774,449 (37%) to $2,895,689 in the Third Quarter FY2012 from $2,121,040 in the Third Quarter FY2011. The increase is primarily attributable to an increase in non-cash charges of approximately $238,386 for employee stock options & warrants issued to employees & board members in the current year, an increase of approximately $213,000 in legal expenses primarily associated with our recently completed financing, approximately $60,000 associated with our recent shareholder meeting and approximately $275,000 for consulting services paid for in stock.
 
 
 Net interest expense in the Third Quarter FY2012 increased $460,710 (218%) to $672,373 from $211,663 in the Third Quarter FY2011 as a result of our increased debt levels, primarily our 10% demand note payable to a member of our Board of Directors, and the amortization of the debt discount & warrant expense of $366,830 & beneficial conversion feature expense of $70,641 on the financing completed in the third quarter.
 
 
Our net loss for the Third Quarter FY2012 increased $1,018,603 to $3,272,639 from $2,254,036 in the Third Quarter FY2011, primarily as a result of the increased legal, shareholder meeting, stock option and consulting expenses noted above, partially offset by the decrease in engineering, research and development expenses, and the increase in the interest expense noted above.
 
 

 
 

 
 
16

 
 

 
Nine months FY 2012 compared to nine months FY 2011
 
 
Net revenues for the nine months ended November 30, 2011 (the “Nine Months FY2012”) decreased $741,767 to $2,093,955, from $2,835,722 in the nine months ended November 30, 2010 (the “Nine Months FY2011”), a decrease of 26%. Subsequent to the end of the Nine Months FY2012, an ongoing customer placed an order for approximately $610,000 to be delivered in the fourth quarter. This customer in the past has typically ordered for delivery in the third quarter. Our customers typically order on an as needed basis and therefore our sales can fluctuate substantially between periods based on our customers’ needs at a given time.
 
 
Cost of goods decreased $484,416 to $997,948 in the Nine Months FY2012, from $1,482,364 in the Nine Months FY2011, a decrease of 33%, as a result of the decrease in sales. Cost of goods can vary at a different rate than our sales as a result of the mix of the different systems that are sold. Typically, 8kW systems and component parts carry a higher gross margin than 5kW systems, so our cost of sales and resulting gross margin is affected by the sales in each category.
 
 
Engineering, research and development expenses decreased $291,289 (23%) to $993,411 in the Nine Months FY2012 from $1,284,700 in the Nine Months FY2011. We have continued to reduce our expenditures in this area due to our financial situation.
 
 
Selling, general and administrative expenses increased $3,558,038 (49%) to $10,755,327 in the Nine Months FY2012 from $7,197,289 in the Nine Months FY2011.    The increase is primarily attributable to non-cash charges of $3,750,513 for stock options and warrants issued to employees and board members in the current year,  increased legal expenses of approximately $141,000 related primarily to our recently completed financing, partially offset by a reduction of approximately $135,000 in marketing and investor relations expenses.
 
 
Net interest expense in the Nine Months FY2012 increased $506,074 (76%) to $1,176,358 from $670,284 in the Nine Months FY2011 as a result of our increased debt levels, primarily the 10% demand note from a member of our Board of Directors, which has increased from $8,500,000 at February 28, 2011 to $9,975,000 at November 30, 2011, and the amortization of the debt discount & warrant expense of $366,830 & beneficial conversion feature expense of $70,641 on the financing completed in the third quarter.
 
 
Our net loss for the Nine Months FY2012 increased $3,238,637 (41%) to $11,099,713 from $7,861,076 in the Nine Months FY2011 primarily as a result of the increase in  non-cash charges for the amortization of expenses associated with the employee stock option plan in the current year, increased legal expenses noted above,  partially offset by a reduction in marketing and investor relations and engineering, research and development  expenses noted above, and the increased interest expense noted above.
 
 
Liquidity and Capital Resources
 
 
We had cash of approximately $146,000 and $105,000 as of November 30, 2011, and February 28, 2011, respectively.  We had a working capital deficit at November 30, 2011, and February 28, 2011 of $10,964,378 and $13,583,433, respectively. The working capital deficit includes notes payable and accrued interest to related parties of $11,367,506 and $10,148,352 as of November 30 and February 28, 2011, respectively, including a convertible note payable of $360,000 to our CEO at February 28, 2011.  As of November 30, 2011, we had accounts receivable, net of allowance for doubtful accounts, of $546,984 compared to $296,297 as of February 28, 2011. 
 
 
Net cash used in operations for the nine months ended November 30, 2011, was $5,991,578, an increase of $1,396,989 from the comparable period in the prior fiscal year. Net cash provided by financing activities during the nine months ended November 30, 2011, was $6,033,020, resulting from net proceeds from notes payable of $4,579,500, along with proceeds from the sale of Common Stock totaling $1,453,520.
 
 
There were no acquisitions of property and equipment in the nine months FY 2012, compared to acquisitions totaling $9,599 in the nine months FY2011.
 
 
 
17

 
 
Accrued expenses as of November 30, 2011 decreased $1,727,791 to $905,065 from $2,632,856 as of February 28, 2011. Approximately $525,000 of accrued expenses is salaries accrued but unpaid to certain ex-employees due to a lack of resources, and approximately $240,000 is accrued but unused vacation time earned by employees.
 
 
Net proceeds from the issuance of debt totaled $4,579,500 in the nine months FY 2012, compared with $3,055,000 in the nine months FY 2011. Included in the debt proceeds of $4,579,500 in the nine months of FY2012 is a total of $975,000 from a member of our Board of Directors. As of December 31, 2011, the total amount owing this board member is $9,725,000 plus accrued interest of approximately $2,150,000. If the Board member were to demand repayment, we do not currently have the resources to make the payment.
 
 
The Company had a deficit of $8,926,007 in shareholders’ equity as of November 30, 2011, compared to $11,428,578 as of February 28, 2011. The deficit includes approximately $12.1 million of non-cash expenses resulting from charges for stock option and warrant expense for fiscal years 2008 through the first nine months of fiscal year 2012.
 
Since 2002 substantially all of our revenues from operations have been derived from sales of the AuraGen®. The cash flow generated from our operations to date has not been sufficient to fund our working capital needs, and we cannot predict when operating cash flow will be sufficient to fund working capital needs.
 
In the past, in order to maintain liquidity we have relied upon external sources of financing, principally equity financing and private indebtedness. We have no bank line of credit and require additional debt or equity financing to fund ongoing operations. The issuance of additional shares of equity in connection with any such financing could dilute the interests of our existing stockholders, and such dilution could be substantial. If we cannot raise needed funds, we would also be forced to make further substantial reductions in our operating expenses, which could adversely affect our ability to implement our current business plan and ultimately our viability as a company.
 
 
Capital Transactions
 
 
During the quarter ended November 30, 2011, we issued 310,000 shares of Common Stock for cash consideration of $232,500, with 310,000 warrants attached at an exercise price of $1.00-$1.25. We also issued 725,000 shares of Common Stock for services to be rendered in the amount of $510,000, and 426,666 shares of Common Stock as finders fees with 490,000 warrants attached at an exercise price of $0.75.
 
 
During the quarter ended November 30, 2010, we issued 635,636 shares of Common Stock for cash consideration of $328,969. We also issued 103,408 shares of Common Stock for the conversion of $56,874 of notes payable and accrued interest, 50,000 shares of common stock as finders fees, and 132,556 shares of  Common Stock for the settlement of $89,040 of accounts payable.
 
 
Inventories
 
 
Inventories consist primarily of components and completed units of the Company’s AuraGen® product.
 
 
Early in our AuraGen® program, we determined it was most cost-effective to outsource production of components and subassemblies to volume-oriented manufacturers, rather than produce these parts in house. As a result of this decision, and based on then anticipated sales, we purchased, prior to fiscal 2001, a substantial inventory of components at volume prices, most of which was then assembled into finished AuraGen® units. Since sales did not meet such expectations, we have been selling product from this inventory for several years. Management has analyzed its inventories based on its current business plan, current potential orders for future delivery, and pending proposals with prospective customers and has determined we do not expect to realize all of its inventories within the next year. The net inventories as of November 30 and February 28, 2011, which are not expected to be realized within a 12-month period have been reclassified as long term.
 
 
 
18

 
 
Most of our inventory consists of a variety of (i) metallic, mechanical components, and (ii) electrical components including metallic chassis to hold the assembled electrical systems.  The vast majority of mechanical components are not aged and most of the electrical components are also not aged.  The components that are aged are related to the prime mover/Generator interface that may not be in demand any longer.
 
 
Currently, we offer and ship three different basic models of systems; (i) a 5 kW based systems, (ii) an 8.5 kW based system and (iii) a 16 kW based systems (two 8.5 kW systems configured in tandem back-to-back).  Each of these systems can be configured with different options such as 110 VAC only, 220 VAC only, 24 VDC only, 12 VDC only and AC/DC combinations of the same or different voltages.  In addition, the system can be configured with single phase, split phase or three-phase output.
 
 
A number of the mechanical components are common to all three of the above configurations, while others are very specific.  For example, the stators and rotors for the 5 kW systems are different from the 8.5 kW systems, but the housings are the same.  Similarly, the electrical components consist of some parts that are geared for a specific configuration while others are generic and can be used for all of the configurations.   The electrical chassis are also interchangeable between the 5 kW and 8.5 kW configurations. Due to the nature and mix of the product being sold, frequently, the 5 kW electrical systems are upgraded to 8.5 kW systems by replacing some components.
 
 
From the above description one can understand that the inventory consists of numerous components and subassemblies but not finished systems; therefore each system that is sold and shipped to a customer is built from some components that are in inventory and others that need to be purchased to be able to configure the required system.
 
 
Currently, most of the product being shipped consists of 8.5 kW systems.  These systems are built by using existing inventory subassemblies and parts, including some that can be used for both 5 kW and 8.5 kW systems, and additional parts that are purchased to provide the required configuration.  Typically such systems are built using approximately 20 to 25 percent of existing inventory and approximately 75% of additional parts that are purchased.
 
 
However, most of the systems currently being sold to the Korean military consist of 5 kW systems.  They have been purchasing approximately 100 systems per year and have indicated to us that they will continue to do so for the next six years.  To date we have shipped over 400 such systems (in this case 100% of the rotors and stators are used from existing inventory and over 50% of the electrical parts are also from inventory).
 
 
In addition to the above, we constantly see demand for different and unique configurations that require the purchase of additional parts.
 
 
ITEM 4T.  Controls and Procedures
 

 
Evaluation of Disclosure Controls and Procedures
 


 
Disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit, is recorded, processed, summarized and reported, within the time periods specified in the U.S. Securities and Exchange Commission’s rules and forms, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosures.   Our Chief Executive Officer and Chief Financial Officer have evaluated our disclosure controls and procedures and have concluded, as of November 30, 2011, that they were effective.
 


 
Changes in Internal Control over Financial Reporting
 

 
There have been no changes in our internal control over financial reporting during our fiscal quarter ended November 30, 2011, which have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
 

 
19

 

PART II - OTHER INFORMATION
 
ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds
 
 
During the nine months ended November 30, 2011, we issued 2,460,849 shares of Common Stock for cash consideration of $1,453,520. We also issued 2,227,612 shares of Common Stock for the conversion of $1,515,960 of notes payable and accrued interest, 1,225,000 shares of Common Stock for services to be rendered in the amount of $885,000, 908,593 shares of Common Stock in satisfaction of $599,492 of accounts payable, 859,999 shares as finders fees, and 3,042,199 shares of Common Stock in satisfaction of $2,259,865 of accrued and unpaid compensation.
 
All of the sales of unregistered securities are believed to be exempt from registration pursuant to Section 4(2) of the Securities Act of 1933 as these offerings were a private placement to a limited number of qualified investors without public solicitation or advertising.


ITEM 6.  Exhibits

10.63
  Demand Promissory Note dated September 16, 2011 by and between the Company and Warren Breslow in the original principal amount of $250,000.
10.64
  Demand Promissory Note dated September 23, 2011 by and between the Company and Warren Breslow in the original principal amount of $250,000.
31.1             Certifications pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.
31.2             Certifications pursuant to Rule 13a-14 under the Securities Exchange Act of 1934.
32.1             Certification of CEO and CFO Pursuant to 18 U.S.C. § 1350, as Adopted Pursuant to § 906 of theSarbanes-Oxley Act of 2002.
 
101.INS    XBRL Instance Document
 
101.SCH  XBRL Schema Document
 
101.CAL  XBRL Calculation Linkbase Document
 
101.LAB  Label Linkbase Document
 
101.PRE  Presentation Linkbase Document
 
101.DEF Definition Linkbase Document
 

 


 
20

 


 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
                  AURA SYSTEMS, INC.          
 
 
                  (Registrant)
 
 
Date: January 17, 2012                             
 
 
By:    /s/ Melvin Gagerman      
 
 
Melvin Gagerman
 
 
Chief Financial Officer
 
 
(Principal Financial and Accounting Officer
 
 
and Duly Authorized Officer)
 

 
21